Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1999-03-29
2000-12-19
Low, Christopher S. F.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 530324, 530350, A61K 3800, C07K 1700
Patent
active
061627887
ABSTRACT:
The present invention relates to methods for treating chlamydial infection comprising administering to a subject suffering from a chlamydial infection a bactericidal/permeability-inducing (BPI) protein product.
REFERENCES:
patent: 5089274 (1992-02-01), Marra et al.
patent: 5171739 (1992-12-01), Scott et al.
patent: 5198541 (1993-03-01), Elsbach et al.
patent: 5234912 (1993-08-01), Marra et al.
patent: 5308834 (1994-05-01), Scott et al.
patent: 5334584 (1994-08-01), Scott et al.
patent: 5348942 (1994-09-01), Little II et al.
patent: 5420019 (1995-05-01), Theofan et al.
patent: 5439807 (1995-08-01), Grinna et al.
patent: 5447913 (1995-09-01), Ammons et al.
patent: 5466580 (1995-11-01), White et al.
patent: 5466581 (1995-11-01), White et al.
patent: 5484705 (1996-01-01), White et al.
patent: 5488034 (1996-01-01), McGregor et al.
patent: 5494896 (1996-02-01), Hansbrough
patent: 5523288 (1996-06-01), Cohen et al.
patent: 5532216 (1996-07-01), Espevik et al.
patent: 5576292 (1996-11-01), Elsbach et al.
patent: 5578568 (1996-11-01), Ammons et al.
patent: 5578572 (1996-11-01), Horwitz et al.
patent: 5627153 (1997-05-01), Little et al.
patent: 5639727 (1997-06-01), Little et al.
patent: 5641874 (1997-06-01), Elsbach et al.
patent: 5643570 (1997-07-01), Theofan et al.
patent: 5643875 (1997-07-01), Friedman et al.
patent: 5646114 (1997-07-01), Lambert
patent: 5652332 (1997-07-01), Little
patent: 5674834 (1997-10-01), Theofan et al.
patent: 5696090 (1997-12-01), McGregor et al.
patent: 5703038 (1997-12-01), Ammons et al.
patent: 5733872 (1998-03-01), Little
patent: 5888973 (1999-03-01), Lambert, Jr.
Alexander et al., "Role of Chlamydia trachomatis in Perinatal Infection, " Rev. Infect. Dis., 5(4):713-719 (Jul.-Aug. 1983).
Becker, "The Chlamydia: Molecular Biology of Procaryotic Obligate Parasites of Eucaryocytes," Microbiol., Rev., 42(2):274-306 (Jun. 1978).
Beatty et al., "Persistent Chlamydiae: from Cell Culture to a Paradigm for Chlamydial Pathogenesis," Microbiol. Rev., 58(4):686-699 (Dec., 1994).
Brade et al., "Antigenic Properties of Chlamydia trachomatis Lipoplysaccharide," Infect.Immun., 48(2):569-572 (May, 1985).
Brade et al., "Chlamydial lipopolysaccharide," J. Endotoxin Res., 4(1):67-84 (1997).
Brade et al., "Chlamydial LPS: More than a Genus-Specific Antigen?," Chlamydial Infections, Proceedings of the 8th Int'l Symposium on Human Chlamydial Infections Jun. 19-24, 1994, Orfila et al., eds., Societa Editrice Esculapio, Bologna, Italy, pp. 247-250.
Bowie, "Treatment of Chlamydial Infections," Chlamydial Infections, Proceedings of the 8th Int'l Symposium on Human Chlamydial Infections Jun. 19-24, 1994, Orfila et al., eds., Societa Editrice Esculapio, Bologna, Italy, pp. 621-630.
Campbell et al., "Detection of Chlamydia Pneumoniae in Atherectomy Tissue From Patients with Symptomatic Coronary Artery Disease," Chlamydial Infections, Proceedings of the 8th Int'l Symposium on Human Chlamydial Infections Jun. 19-24, 1994, Orfila et al., eds., Societa Editrice Esculapio, Bologna, Italy, pp. 212-215.
Chen et al., "Differences in High Affinity Binding of Heparin To Trachoma and LGV Biovars of Chlamydia Trachomatis," Chlamydial Infections, Proceedings of the 8th Int'l Symposium on Human Chlamydial Infections Jun. 19-24, 1994, Orfila et al., eds., Societa Editrice Esculapio, Bologna, Italy, pp. 387-390.
Elsbach and Weiss, "Oxygen-Independent Antimicrobial Systems of Phagocytes," In Inflammation: Basic Principles and Clinical Correlates, Chapter 30, Gallin et al., (Eds.), Second Edition, Raven Press, Ltd., New York, pp. 603-636 (1992).
Gaydos et al., "Growth Characteristics of Chlamydia Pneumoniae in Macrophages and Endothelial Cells," Chlamydial Infections, Proceedings of the 8th Int'l Symposium on Human Chlamydial Infections Jun. 19-24, 1994, Orfila et al., eds., Societa Editrice Esculapio, Bologna, Italy, pp. 216-219.
Elsbach et al., "Separation and Purification of a Potent Bactericical/Permeability Increasing Protein and a Closely Associated Phospholipase A.sub.2 From Rabbit Polymorphonuclear Leukocytes," J. Biol. Chem., 254(21):11000-11009 (Nov. 10, 1979).
Gazzano-Santoro et al., "High-Affinity Binding of the Bactericidal/Permeability-Increasing Protein and a Recombinant Amino-Terminal Fragment to the Lipid A Region of Lipopolysaccharide," Infect. Immun. 60(11):4754-4761 (Nov., 1992).
Gray et al., "Cloning of the cDNA of a Human Neutrophil Bactericidal Protein," J. Biol. Chem., 264(16):9505-9509 (Jun. 5, 1989).
Grayston et al., Chlamydial Infections, Proceedings of the 8th Int'l Symposium on Human Chlamydial Infections Jun. 19-24, 1994, Orfila et al., eds., Societa Editrice Esculapio, Bologna, Italy, pp. 199-208.
Grayston et al., "New Knowledge of Chlamydie and the Diseases They Cause," J. Infect. Dis.,132(1):87-105 (Jul. 1975).
Hatch et al., "Identification of a Major Envelope Protein in Chlamydia spp.," J. Bacteriol., 146(1):426-429 (Apr. 1981).
In't Veld et al., "Effects of the Bactericidal/Permeability-Increasing Protein of Polymorphonuclear Leukocytes on Isolated Bacterial Cytoplasmic Membrane Vesicles," Infection and Immunity, 56(5):1203-1208 (May, 1988).
Leinonen et al., "Chlamydia Pneumoniae-Specific Antibodies and Immune Complexes in German Patients with Acute Myocardial Infarction," Chlamydial Infections, Proceedings of the 8th Int'l Symposium on Human Chlamydial Infections Jun. 19-24, 1994, Orfila et al., eds., Societa Editrice Esculapio, Bologna, Italy, pp. 209-211.
Levy et al., "Antibacterial 15-kDa Protein Isoforms (p15s) Are Members of a Novel Family of Leukocyte Proteins," J. Biol. Chem., 268(8):6058-6063 (Mar. 16, 1993).
Lycke, "Assaying Antichlamydial Drugs in Vitro," Scand. J. Infect. Dis. Suppl. 32:38-41 (1982).
Mannion et al., "Separation of Sublethal and Lethal Effects of Polymorphonuclear Leukocytes on Escherichia coli," J. Clin. Invest., 86:631-641 (Aug., 1990).
Mannion et al., "Separation of Sublethal Effects of the Bactericidal/Permeability Increasing Protein on Escherichia coli," J. Clin. Invest., 85:853-860 (Mar., 1990).
McCormack, W.M., (Ed.), "Chlamydia Monograph," Abbott Diagnostics Educational Services, pp. 3-23, 1983.
Nurminen et al., "Chemical Characterization of Chlamydia trachomatis Lipopolysaccharide," Infect. Immun., 48(2):573-575 (May 1985).
Nurminen et al., "The Genus-Specific Antigen of Chlamydia: Resemblance to the Lipopolysaccharide of Enteric Bacteria," Science 220:1279-1281 (Jun. 17, 1983).
Ooi et al., "25-kDa NH.sub.2 -Terminal Fragment Carries All the Antibacterial Activities of the Human Neutrophil 60-kDa Bactericidal/Permeability-Increasing Protein," J. Biol. Chem., 262(31):14891-14894 (Nov. 5, 1987).
Ooi et al., "Endotoxin Neutralizing Properties of the 25 kD N-Terminal Fragment of the 55-60 kD Bactericidal/Permeability-Increasing Protein of Human Neutrophils," J. Exp. Med., 174:649-655 (Sep., 1991).
Peeling et al., "Standardization of Antimicrobial Susceptibility Testing for Chlamydia trachomatis," Chlamydial Infections, Proceedings of the 8th Int'l Symposium on Human Chlamydial Infections Jun. 19-24, 1994, Orfila et al., eds., Societa Editrice Esculapio, Bologna, Italy, pp. 346-349.
Salari et al., "Polypeptide Composition of Chlamydia trachomatis," J. General Microbiol., 123:197-207 (1981).
Ooi et al., "Isolation of Two Isoforms of a Novel 15-kDa Protein from Rabbit Polymorphonuclear Leukocytes That Modulate the Antibacterial Actions of Other Leukocyte Proteins," J. Biol. Chem., 265:15956-15962 (Sep. 15, 1990).
Schacter and Stamm, "Chlamydia," In: Manual of Clinical Microbiology, American Society for Microbiology, Washington, DC, pp. 669-677 (1995).
Schacter et al., "In Vitro Activity of Ciprofloxacin against Chlamydia trachomatis," Am. J. Med., 82 (Suppl. 4A):42-43 (Apr. 27, 1987).
Stephens, "Cell Biology of Chlamydia Infection," Chlamydial Infections, Proceedings of the 8th Int'l Symposium on Human Chlamydial Infections Jun. 19-24, 1994, Orfila et al., eds., Societa Editrice Esculapio, Bologna, Italy, pp. 377-386.
Walker and Dasch, "Classification and Identification of Chlamydia, Rickettsia, and Related Bacteria," pp. 665-668, 1993.
Low Christopher S. F.
Mohamed Abdel A.
Xoma Corporation
LandOfFree
Uses of BPI protein products does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Uses of BPI protein products, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses of BPI protein products will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-271341